Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study

Aristotelis Bamias, Ian D. Davis, Matthew D. Galsky, José Ángel Arranz, Eiji Kikuchi, Enrique Grande, Xavier García del Muro, Se Hoon Park, Ugo De Giorgi, B. Yа. Alekseev, Marina Mencinger, Kouji Izumi, Fabio A.B. Schutz, Javier Puente, Jian‐Ri Li, Stefano Panni, Mahmut Gümüş, Mustafa Özgüroğlu, Sanjeev Mariathasan, Yekaterina Poloz, Fabiola Bene‐Tchaleu, Chooi Lee, Sandrine Bernhard, Maria De Santis